Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5965525 | VICURON HOLDINGS | Cyclic peptide antifungal agents |
Feb, 2020
(4 years ago) | |
US7709444 | VICURON HOLDINGS | Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
Apr, 2021
(3 years ago) | |
US6960564 | VICURON HOLDINGS | Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
Apr, 2021
(3 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Patient Population(NPP) | Sep 22, 2023 |
Market Authorisation Date: 17 February, 2006
Treatment: Treatment of fungal infections
Dosage: POWDER;INTRAVENOUS